XML 32 R13.htm IDEA: XBRL DOCUMENT v3.22.0.1
Equity Method Investments
12 Months Ended
Dec. 31, 2021
Equity Method Investments and Joint Ventures [Abstract]  
Equity Method Investments Equity Method Investments
For each of the following investments, we have the ability to exercise significant influence over these investments based on certain governance provisions and our participation in the significant activities and decisions that impact the management and economic performance of the investments.
Equity method investments comprise the following as of the dates indicated:  
December 31,
20212020
OwnershipAmountOwnershipAmount
Mattox79.0%$156 79.0%$163 
Amberjack – Series A / Series B
75.0% / 50.0%
359 
75.0% / 50.0%
382 
Mars71.5%150 71.5%152 
Bengal50.0%85 50.0%88 
Permian Basin50.0%80 50.0%83 
LOCAP41.48%15 41.48%12 
Explorer38.59%68 38.59%73 
Poseidon 36.0%— 36.0%— 
Colonial16.125%32 16.125%29 
Proteus10.0%13 10.0%14 
Endymion10.0%16 10.0%17 
$974 $1,013 
Impacts to Equity Method Investments

Earnings from our equity method investments were as follows during the periods indicated:
For the Year Ended December 31,
202120202019
Mattox (1)
$60 $45 $— 
Amberjack106 102 125 
Mars83 114 126 
Bengal18 24 
Explorer (2)
61 44 41 
Colonial (2)
18 75 40 
Poseidon (3)
— — — 
Other (4)
15 19 17 
$352 $417 $373 
(1) We acquired an interest in Mattox in the April 2020 Transaction. The acquisition of this interest has been accounted for prospectively.
(2) We acquired additional interests in Explorer and Colonial in the June 2019 Acquisition. The acquisition of these interests has been accounted for prospectively.
(3) As stated below, the equity method of accounting has been suspended since early 2018 for Poseidon and excess distributions are recorded in Other income.
(4) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

For the years ended December 31, 2021, 2020 and 2019, distributions received from equity method investments were $433 million, $541 million and $466 million, respectively.

Unamortized differences in the basis of the initial investments and our interest in the separate net assets within the financial statements of the investees are amortized into net income over the remaining useful lives of the underlying assets. The amortization is included in Income from equity method investments. As of December 31, 2021 and 2020, the unamortized basis differences included in our equity method investments were $75 million and $84 million, respectively. For the years ended 2021, 2020 and 2019, the net amortization expense was $9 million, $8 million and $6 million, respectively. Included in the net amortization expense for 2021 is a write-off of approximately $2 million of unamortized basis difference as a result of an impairment taken by Colonial.

Cumulatively, distributions received from Poseidon have been in excess of our investment balance and, therefore, the equity method of accounting has been suspended for this investment and the investment amount reduced to zero. As we have no commitments to provide further financial support to Poseidon, we have recorded excess distributions of $39 million, $37 million and $33 million in Other income for the years ended December 31, 2021, 2020 and 2019, respectively. Once our cumulative share of equity earnings becomes greater than the cumulative amount of distributions received, we will resume the equity method of accounting as long as the equity method investment balance remains greater than zero.

Transactions
We acquired a 79% interest in Mattox from SGOM in the April 2020 Transaction. This investment qualifies for equity method accounting, as we exercise significant influence but do not control this investment. Upon acquisition, we recorded SGOM’s historical carrying value of the equity interests transferred as a transaction between entities under common control, totaling $174 million. We recognize equity earnings for Mattox prospectively from the date of acquisition, and record the distributions from Mattox as a reduction to the equity method investment balance.

We acquired an additional 25.97% interest in Explorer and an additional 10.125% interest in Colonial in the June 2019 Acquisition. As a result, these investments now qualify for equity method accounting as we have the ability to exercise significant influence over these investments as of the acquisition date. Prior to the acquisition date, Explorer and Colonial were accounted for as Other investments without readily determinable fair values and were therefore carried at cost. Upon acquisition, we added our Parent’s historical carrying value of the equity interests transferred as a transaction between entities under common control, totaling $90 million, to the basis of our previously held interests of $60 million as this is the date these investments qualified for equity method accounting. Since the June 2019 Acquisition, we record distributions from these investments as reductions to the respective equity method investment balances for Explorer and Colonial as these amounts are
no longer considered dividend income due to the change in the method of accounting. We recognize equity earnings for both Explorer and Colonial prospectively from the date of acquisition.

Significant Developments
The board of directors of Colonial elected not to declare a dividend for each of the three months ended June 30, 2021, September 30, 2021 and December 31, 2021.

During the fourth quarter of 2021, Colonial recorded an impairment, of which our share was approximately $44 million, that negatively impacted both our income from equity method investments and net income.

Effective June 4, 2021, Amberjack executed an agreement to divest a small segment of the Amberjack pipeline that is no longer utilized nor deemed a material component in the operation of the pipeline. As a result of the divestment, Amberjack recorded an impairment charge of approximately $4 million during the second quarter of 2021. Our share of approximately $3 million impacted our Income from equity method investments in our consolidated statements of income. The remainder of the Amberjack pipeline continues to operate under its existing ownership structure.

Under the lease standard, the adoption date for our equity method investments will follow the non-public business entity adoption date of January 1, 2020 for their stand-alone financial statements, with the exception of Permian Basin, which adopted on January 1, 2019. There has been no material impact on the Partnership’s consolidated financial statements as a result of the adoption of the lease standard by our equity method investees.

On October 23, 2019, we entered into a Settlement Agreement with SPLC (the “Settlement Agreement”) with respect to the storage revenue reimbursement provision contained in the Purchase and Sale Agreement entered into in 2016 under which we acquired an additional 20% interest in Mars. Pursuant to this Purchase and Sale Agreement, SPLC had agreed to pay us up to $10 million if Mars inventory management fees do not meet certain levels for the calendar years 2017 through 2021. As a result of the Settlement Agreement, we received approximately $9 million during the fourth quarter of 2019 from SPLC that was recognized as an additional capital contribution.

Capital Contributions
We make capital contributions for our pro rata interest in Permian Basin to fund capital and other expenditures. We made capital contributions to Permian Basin of approximately $4 million and $25 million in 2021 and 2019, respectively. We did not make any capital contributions in 2020.

Impairment Assessment
We assess our equity method investments for impairment whenever changes in the facts and circumstances indicate a loss in value has occurred, if the loss is deemed to be other-than-temporary. When the loss is deemed to be other-than-temporary, the carrying value of the equity method investment is written down to fair value. We evaluated whether an impairment indicator existed as of December 31, 2021. Based on expectations of market conditions, we determined that there was no triggering event that required us to update our impairment evaluation of our equity method investments. However, if the facts and circumstances change in the near-term and indicate a loss in value that is other-than-temporary, we will re-evaluate whether the carrying amount of our equity method investments may not be recoverable.
Summarized Financial Information
The following tables present aggregated selected balance sheet and income statement data for our equity method investments on a 100% basis. However, during periods in which an acquisition occurs, the selected balance sheet and income statement data reflects activity from the date of the acquisition.
 
For the Year Ended December 31, 2021
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Mattox$88 $12 $76 $76 
Amberjack271 66 205 203 
Mars211 91 120 120 
Bengal46 29 17 17 
Explorer405 178 227 165 
Colonial1,304 1,002 302 123 
Poseidon134 37 97 93 
Other (1)
213 126 87 82 
As of December 31, 2021
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Mattox$11 $195 $206 $— $$197 $206 
Amberjack53 786 839 134 700 839 
Mars50 245 295 26 79 190 295 
Bengal28 164 192 11 — 181 192 
Explorer85 574 659 54 508 97 659 
Colonial695 3,008 3,703 307 3,503 (107)3,703 
Poseidon18 167 185 232 (55)185 
Other (1)
33 871 904 43 459 402 904 
(1) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.

For the Year Ended December 31, 2020
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Mattox (1)
$66 $$57 $57 
Amberjack280 78 202 201 
Mars259 97 162 163 
Bengal65 30 35 35 
Explorer329 175 154 119 
Colonial1,395 660 735 473 
Poseidon147 36 111 105 
Other (2)
220 123 97 88 
As of December 31, 2020
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Mattox (1)
$13 $204 $217 $— $12 $205 $217 
Amberjack44 836 880 10 124 746 880 
Mars47 269 316 23 103 190 316 
Bengal33 161 194 — 187 194 
Explorer74 537 611 49 459 103 611 
Colonial501 3,105 3,606 245 3,508 (147)3,606 
Poseidon31 176 207 10 238 (41)207 
Other (2)
35 920 955 56 486 413 955 
(1) Our interest in Mattox was acquired in the April 2020 Transaction. Mattox’s total revenues, total operating expenses and operating income (on a 100% basis) were $85 million, $12 million and $73 million, respectively.
(2) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.
For the Year Ended December 31, 2019
Total revenuesTotal operating expensesOperating incomeNet income
Statements of Income
Amberjack
$315 $73 $242 $243 
Mars282 104 178 179 
Bengal77 30 47 47 
Explorer (1)
258 115 143 111 
Colonial (2)
829 449 380 255 
Poseidon132 35 97 87 
Other (3)
190 108 82 73 
As of December 31, 2019
Current assetsNon-current assetsTotal assetsCurrent liabilitiesNon-current liabilitiesEquity (deficit)Total liabilities and equity (deficit)
Balance Sheets
Amberjack
$56 $804 $860 $$32 $824 $860 
Mars57 173 230 22 200 230 
Bengal35 157 192 — 186 192 
Explorer (1)
93 530 623 44 442 137 623 
Colonial (2)
323 2,920 3,243 519 2,873 (149)3,243 
Poseidon30 190 220 16 246 (42)220 
Other (3)
60 917 977 73 469 435 977 
(1) Our interest in Explorer was acquired on June 6, 2019. Explorer total revenues, total operating expenses and operating income (on a 100% basis) was $443 million, $196 million and $247 million, respectively.
(2) Our interest in Colonial was acquired on June 6, 2019. Colonial total revenues, total operating expenses and operating income (on a 100% basis) was $1,437 million, $735 million and $702 million, respectively.
(2) Included in Other is the activity associated with our investments in Permian Basin, LOCAP, Proteus and Endymion.